Optimizing LC-MS Blank-Injection Documentation for Research Peptide Carryover Review
Purpose and scope
This article outlines a technical framework for documenting blank injections and recording carryover evaluations in LC-MS workflows used for peptide research. The goal is to describe the metadata and recordkeeping elements that support reproducible carryover review records and to explain how carryover percentages are commonly represented in analytical documentation. The content focuses on traceability, equipment records, analytical-method metadata, and controlled documentation practices rather than operational step-by-step procedures.
Key elements of carryover review records
Carryover review records should capture enough context to interpret blank-injection results later. Useful elements include: sample identifiers and batch IDs; sequence run identifiers; blank injection positions in the sequence; instrument and column identifiers with serial numbers; autosampler and plate configuration metadata; acquisition method name and version; and timestamps for run start and completion. Each entry should reference the analytical-method metadata set used for acquisition and processing so that downstream reviewers can trace measured values back to method versions and equipment history.
Analytical-method metadata and equipment records
Maintaining a clear link between analytical-method metadata and instrument/equipment records improves traceability. Analytical-method metadata can document acquisition parameters, integration settings, processing algorithms, and calibration file versions. Equipment records should note last service or maintenance events, consumable changes (for example, column change or autosampler needle replacement), and any observed performance anomalies. Including these items in the carryover review record allows correlation of blank-injection behavior with recent equipment events without asserting specific causal relationships.
Documenting blank injections and calculating carryover
Blank-injection entries in a sequence log commonly include measured response values (for example, peak area or height) and the identity of the preceding sample or standard. A clear, consistently applied method for calculating a carryover percentage aids comparability across runs and instruments. One common representation is a ratio of the blank response to the preceding sample response, expressed as a percentage (carryover % = (blank response / sample response) × 100). In documentation, record both the raw values and the calculated percentage, along with the method version used for peak integration and any qualifiers applied during review.
Controlled documentation practices
Controlled documentation should specify required fields, acceptable formats, and retention expectations for carryover records. Electronic records benefit from immutable audit trails, user attribution, and timestamping for each change. When paper records are used, cross-references to electronic datasets and scans can preserve linkage. Use consistent identifiers (run IDs, method versions, instrument IDs) and maintain a central index that maps these identifiers to the full metadata and equipment histories needed for later review.
Data review, traceability, and archival
Review procedures for carryover records should focus on traceability: ability to reconstruct the acquisition context, processing choices, and equipment state at the time of measurement. Archive raw chromatograms, processed reports, method files, and equipment logs together with the summary carryover entries. Consider structured record formats (CSV, JSON, or laboratory information management system entries) that preserve associations between fields and support automated queries for trend analysis over time.
References
For technical discussion of carryover mechanisms in LC-MS peptide analyses, see: Troubleshooting Carry-Over in the LC-MS Analysis of Biomolecules: The Case of Neuropeptide Y.
Research Use Only Notice
Not for human consumption. For laboratory research use only.